1. Home
  2. CCK vs GKOS Comparison

CCK vs GKOS Comparison

Compare CCK & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCK
  • GKOS
  • Stock Information
  • Founded
  • CCK 1906
  • GKOS 1998
  • Country
  • CCK United States
  • GKOS United States
  • Employees
  • CCK N/A
  • GKOS N/A
  • Industry
  • CCK Containers/Packaging
  • GKOS Medical/Dental Instruments
  • Sector
  • CCK Industrials
  • GKOS Health Care
  • Exchange
  • CCK Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • CCK 10.4B
  • GKOS 5.1B
  • IPO Year
  • CCK N/A
  • GKOS 2015
  • Fundamental
  • Price
  • CCK $97.33
  • GKOS $90.52
  • Analyst Decision
  • CCK Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • CCK 12
  • GKOS 13
  • Target Price
  • CCK $108.83
  • GKOS $135.15
  • AVG Volume (30 Days)
  • CCK 1.3M
  • GKOS 1.1M
  • Earning Date
  • CCK 04-28-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • CCK 1.07%
  • GKOS N/A
  • EPS Growth
  • CCK 33.50
  • GKOS N/A
  • EPS
  • CCK 4.63
  • GKOS N/A
  • Revenue
  • CCK $11,904,000,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • CCK $2.43
  • GKOS $27.84
  • Revenue Next Year
  • CCK $2.48
  • GKOS $27.88
  • P/E Ratio
  • CCK $21.03
  • GKOS N/A
  • Revenue Growth
  • CCK 0.71
  • GKOS 23.92
  • 52 Week Low
  • CCK $70.84
  • GKOS $77.10
  • 52 Week High
  • CCK $98.48
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • CCK 68.26
  • GKOS 46.57
  • Support Level
  • CCK $96.89
  • GKOS $84.26
  • Resistance Level
  • CCK $98.37
  • GKOS $89.62
  • Average True Range (ATR)
  • CCK 2.12
  • GKOS 3.97
  • MACD
  • CCK 0.91
  • GKOS 0.49
  • Stochastic Oscillator
  • CCK 92.46
  • GKOS 61.67

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: